TheProfitWatch

ABEO - Abeona Therapeutics Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
5.36 0.09 (1.68%) 0.0 (0.0%) 0.01 (0.18%) 0.03 (0.55%) 0.02 (0.4%) 0.07 (1.3%) 0.0 (0.0%) -0.04 (-0.71%)

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
2.07
Diluted EPS:
1.71
Basic P/E:
2.6329
Diluted P/E:
3.1871
RSI(14) 1m:
73.33
VWAP:
5.45
RVol:
0.4068

Events

Period Kind Movement Occurred At

Related News